| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |